Company / Working Capital
Viatris Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$2.7B
FY2025
5-year range
$1.0B / $5.2B
FY2021-FY2025
Trend
-28.0%
vs FY2024
Sector context
#16 of 213
Health Care
What the data says
Among 213 Health Care companies, Viatris is in the top 8% for working capital. Working Capital has fluctuated over the past 7 years, ranging from $1.0B in FY2021 to $5.2B in FY2023.
Based on SEC 10-K filings.
$2.7B in FY2025 with a 5-year CAGR of +3.2%. Top quartile in the Health Care sector.
Declined from $5.2B to $2.7B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -11.5%
- 5-Year CAGR
- +3.2%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 213This company $2.7B Sector average $934.6M
▼
+188.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.2%, indicating consistent growth.
- In FY2025, working capital decreased 28.0% year-over-year.
- Ranks #16 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7B | -28.0% |
| FY2024 | $3.7B | -28.0% |
| FY2023 | $5.2B | +33.7% |
| FY2022 | $3.9B | +281.9% |
| FY2021 | $1.0B | -55.8% |
| FY2020 | $2.3B | +94.0% |
| FY2019 | $1.2B | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026